Clinical Study to Evaluate the Blood Triglyceride Decreasing Effect and Safety of Korean Post-Fermented Tea Extracts
NCT ID: NCT04850352
Last Updated: 2021-06-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2019-04-03
2021-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Study to Evaluate the Body Fat Reducing Effects of Heat-Treated Green Tea Extract Complex
NCT06609603
Efficacy and Safety of Red Ginseng Concentrated Powder on Improvement of Blood Triglyceride Level
NCT03828188
Artemisia and Green Tea Extracts for Gastric Mucosal Health
NCT06628804
An Examination of Blinding for Chinese Herbal Oral Liquid and Matched Placebo
NCT05483595
A Pilot Study Exploring the Efficacy and Safety of Herbal Medicine on Korean Obese Women With Metabolic Syndrome Risk Factors - Double Blinded, Randomized, Multicenter, Placebo Controlled Clinical Trial -
NCT02651454
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Heukcha Extracts
Take Heukcha Extracts capsule once daily for 8 weeks.
Heukcha Extracts
Experimental group: Heukcha Extracts
Placebo
Take placebo capsule once daily for 8 weeks.
Placebo
Placebo group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Heukcha Extracts
Experimental group: Heukcha Extracts
Placebo
Placebo group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Who has fasting blood triglyceride levels ≥ 150 mg/dL
* Who voluntarily agreed to participate in the study and signed an informed consent form
Exclusion Criteria
* Those who have been diagnosed and are on medication with dyslipidemia, cardiovascular disease, kidney disease, liver disease or thyroid disease within 4 weeks before study participation
* Fasting plasma glucose \>126 mg/dL or treatment with medications including oral hypoglycemic agents or insulin
* Who has used or is expected to inevitably use prohibited concomitant medications during the study
* Women who is pregnant /breast-feeding, or who has childbearing potential and does not use available contraceptives
* Who has dosed other study medications within 30 days before screening
* Who is determined ineligible for study participation by investigators for any other reasons
19 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Amorepacific Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Belong Cho, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Seoul National University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
KangBuk Samsung Medical Center
Seoul, , South Korea
Seoul National University
Seoul, , South Korea
St. Vincent's Hospital, College of Medicine, The Catholic University of Korea
Suwon, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AP-PV-2018-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.